Sector consensus Vaxcyte, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 14/09/2024 am IST			5-day change	1st Jan Change
116.00 ^USD	+1.64%		+3.96%	+84.71%

10/09	Analyst recommendations: Apple, Oracle, Progressive, Dollar Tree...
10/09	Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
VAXCYTE, INC.	145.00	+25.00%	7
VERTEX PHARMACEUTICALS INCORPORATED	509.82	+5.04%	29
REGENERON PHARMACEUTICALS, INC.	1,162.19	+0.77%	25
ARGENX SE	510.75	+4.66%	15
BIONTECH SE	99.35	-10.73%	18
SUMMIT THERAPEUTICS INC.	18.79	-23.10%	3
BEIGENE, LTD.	272.96	+37.52%	21
GENMAB A/S	2,409.94	+33.89%	17
WUXI APPTEC CO., LTD.	58.78	+47.62%	18
INSMED INCORPORATED	87.50	+17.20%	16
NEUROCRINE BIOSCIENCES, INC.	168.72	+38.01%	25
SAREPTA THERAPEUTICS, INC.	194.36	+55.93%	19
ZEALAND PHARMA A/S	1,022.29	+11.66%	7
LEGEND BIOTECH CORPORATION	82.93	+64.84%	19
HALOZYME THERAPEUTICS, INC.	59.10	-5.14%	10
EXELIXIS, INC.	27.52	+4.02%	21
VIKING THERAPEUTICS, INC.	109.70	+64.39%	13
PHARMAESSENTIA CORPORATION	856.00	+25.51%	4
AKESO, INC.	59.56	+6.18%	21
Average	413.43	+21.22%	16
Weighted average by Cap.	609.67	+10.63%	21